System and method for participation in energy-related markets J Crabtree, A McCord, J Jia, O Venn, M Hoak, A Charneski, P Crabtree US Patent App. 12/802,705, 2010 | 704 | 2010 |
Arabidopsis meiotic crossover hot spots overlap with H2A.Z nucleosomes at gene promoters K Choi, X Zhao, KA Kelly, O Venn, JD Higgins, NE Yelina, TJ Hardcastle, ... Nature genetics 45 (11), 1327, 2013 | 372 | 2013 |
System and method for trading complex energy securities J Crabtree, P Rajan, BR Galvin, A McCord, O Venn US Patent App. 12/799,310, 2010 | 355 | 2010 |
System and method for single-action energy resource scheduling and participation in energy-related securities J Crubtree, P Rajan, BR Galvin, A McCord, O Venn US Patent App. 12/584,332, 2010 | 344 | 2010 |
Stable recombination hotspots in birds S Singhal, EM Leffler, K Sannareddy, I Turner, O Venn, DM Hooper, ... Science 350 (6263), 928-932, 2015 | 341 | 2015 |
Multiple instances of ancient balancing selection shared between humans and chimpanzees EM Leffler, Z Gao, S Pfeifer, L Ségurel, A Auton, O Venn, R Bowden, ... Science 339 (6127), 1578-1582, 2013 | 334 | 2013 |
A fine-scale chimpanzee genetic map from population sequencing A Auton, A Fledel-Alon, S Pfeifer, O Venn, L Ségurel, T Street, EM Leffler, ... science 336 (6078), 193-198, 2012 | 333 | 2012 |
A fine-scale chimpanzee genetic map from population sequencing A Auton, A Fledel-Alon, S Pfeifer, O Venn, L Ségurel, T Street, EM Leffler, ... science 336 (6078), 193-198, 2012 | 333 | 2012 |
Strong male bias drives germline mutation in chimpanzees O Venn, I Turner, I Mathieson, N de Groot, R Bontrop, G McVean Science 344 (6189), 1272-1275, 2014 | 183 | 2014 |
Development of a comprehensive cell-free DNA (cfDNA) assay for early detection of multiple tumor types: The Circulating Cell-free Genome Atlas (CCGA) study. EA Klein, E Hubbell, T Maddala, A Aravanis, JF Beausang, D Filippova, ... Journal of Clinical Oncology 36 (15_suppl), 12021-12021, 2018 | 67 | 2018 |
Prevalence of clonal hematopoiesis of indeterminate potential (CHIP) measured by an ultra-sensitive sequencing assay: Exploratory analysis of the Circulating Cancer Genome … C Swanton, O Venn, A Aravanis, E Hubbell, T Maddala, JF Beausang, ... Journal of Clinical Oncology 36 (15_suppl), 12003-12003, 2018 | 52 | 2018 |
50O Plasma cell-free DNA (cfDNA) assays for early multi-cancer detection: The circulating cell-free genome atlas (CCGA) study MC Liu, E Klein, E Hubbell, T Maddala, AM Aravanis, JF Beausang, ... Annals of Oncology 29 (suppl_8), mdy269. 048, 2018 | 43 | 2018 |
Genome-wide sequencing for early stage lung cancer detection from plasma cell-free DNA (cfDNA): The Circulating Cancer Genome Atlas (CCGA) study. GR Oxnard, T Maddala, E Hubbell, A Aravanis, N Zhang, O Venn, ... Journal of Clinical Oncology 36 (18_suppl), LBA8501-LBA8501, 2018 | 30* | 2018 |
Breast cancer cell-free DNA (cfDNA) profiles reflect underlying tumor biology: The Circulating Cell-Free Genome Atlas (CCGA) study. MC Liu, T Maddala, A Aravanis, E Hubbell, JF Beausang, D Filippova, ... Journal of Clinical Oncology 36 (15_suppl), 536-536, 2018 | 29 | 2018 |
Cell-free DNA (cfDNA) mutations from clonal hematopoiesis: Implications for interpretation of liquid biopsy tests. P Razavi, BT Li, C Hou, R Shen, O Venn, RS Lim, E Hubbell, I De Bruijn, ... Journal of Clinical Oncology 35 (15_suppl), 11526-11526, 2017 | 29 | 2017 |
Characterisation of the changing genomic landscape of metastatic melanoma using cell free DNA A Cutts, O Venn, A Dilthey, A Gupta, D Vavoulis, H Dreau, M Middleton, ... NPJ genomic medicine 2 (1), 25, 2017 | 12 | 2017 |
Abstract LB-343: Development of plasma cell-free DNA (cfDNA) assays for early cancer detection: first insights from the Circulating Cell-Free Genome Atlas Study (CCGA) AA Aravanis, GR Oxnard, T Maddala, E Hubbell, O Venn, A Jamshidi, ... Cancer Research 78 (13 Supplement), LB-343-LB-343, 2018 | | 2018 |
Inferring the fine-scale structure and evolution of recombination from high-throughput genome sequencing OC Venn University of Oxford, 2013 | | 2013 |